Scientists engineered phages to act as scaffolds to carry silver nanoparticles. Together, the two bacteria-killing components ...

As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...

In recent news, Nuvation Bio announced it will discontinue the development of NUV-1511, its initial drug-drug conjugate candidate, due to inconsistent efficacy and will redirect resources to other ...

I describe the practical and emotional experiences of living with oculogyric crises caused by antipsychotic use for 25 years.

Today, the CAFC issued a precedential ruling reversing the Eastern District of Texas’ denial of JMOL that Seagen’s patent ...

Daiichi Sankyo has emerged victorious in appeals court, flipping a prior multimillion-dollar patent verdict on its head and ...

A mother tongue is supposed to be the language that sticks with you for life. It is the one you learn before you even ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...

Learn more about whether Ultragenyx Pharmaceutical Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor ...

Learn more about whether TG Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, ...

OncoNano Medicine named Brent Sorrells as chief operating officer to support the Dallas biotech company’s growth and advance ...